Analysis of Clinical Diagnostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined with MRI in Early Breast Cancer

Weiying Ge,Xiujuan Yin,Ruxin Wang,Jianxi Zhao
DOI: https://doi.org/10.1166/jbn.2024.3752
2024-01-21
Journal of Biomedical Nanotechnology
Abstract:A study involving 73 patients with early breast space-occupying diseases (41 malignant, 32 benign) utilized 1.5T quantitative dynamic enhanced magnetic resonance imaging to measure lesion-specific parameters. These included the contrast medium's transfer rate from intravascular to extravascular (K trans ), return rate to blood vessels (K ep ), and tumor vessel volume fraction (V p ). Pathological results post-surgery served as the gold standard. Comparisons between benign and malignant groups, as well as malignant subtypes, were made. Malignant lesions exhibited varied K trans (0.108–2.810 min −1 ) and V p (0.0018–0.743 ml) values. Benign lesions had K trans (0.125–2.472 min −1 ), K ep (0.008–1.760 min −1 ), and V p (0.006–0.816 ml) values. Significant differences were observed in K trans and V p (P < 0.05), but not in K ep and V p (P > 0.05). While differences between hormonal and HER2 statuses were minimal, K ep in HER2-positive tumors was notable (P < 0.05). Subtype comparisons showed no significant K trans variation (P > 0.05) but differences in K ep and V p . In conclusion, K trans is crucial for diagnosing early breast cancer and distinguishing between benign and malignant diseases. The study underscores the potential of quantitative dynamic contrast-enhanced MRI in breast cancer diagnosis
materials science, biomaterials,nanoscience & nanotechnology
What problem does this paper attempt to address?